UBS Group
MDVX

UBS Group’s Medovex Corp. Common Stock MDVX Stock Holding History

UBS Group’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,823
Closed -$6K – 8266
2017
Q2 		$6K Buy
+6,823
New +$7.97K ﹤0.01% 7084
2017
Q1 		– Sell
-3,486
Closed -$5K – 8297
2016
Q4 		$5K Buy
3,486
+382
+12% +$566 ﹤0.01% 7286
2016
Q3 		$5K Buy
3,104
+802
+35% +$1.13K ﹤0.01% 7162
2016
Q2 		$3K Sell
2,302
-446
-16% -$606 ﹤0.01% 7378
2016
Q1 		$3K Sell
2,748
-43,686
-94% -$54.5K ﹤0.01% 7251
2015
Q4 		$51K Buy
46,434
+45,210
+3,694% +$70.3K ﹤0.01% 5802
2015
Q3 		$3K Buy
1,224
+992
+428% +$2.92K ﹤0.01% 7997
2015
Q2 		$1K Sell
232
-3,315
-93% -$13.1K ﹤0.01% 8375
2015
Q1 		$14K Buy
+3,547
New +$16.9K ﹤0.01% 7388

Other funds holding MDVX

MIC
Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
PP
Patten & Patten Chattanooga, Tennessee $1.66B AUM 18.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

UBS Group's MDVX Position: Q3 2017 in Review

UBS Group sold out of Medovex Corp. Common Stock (MDVX) in Q3 2017, closing a stake of 6,823 shares — an estimated $6K sold.

UBS Group first reported a position in MDVX in Q1 2015 and held it in 9 quarters. The position peaked at $51K in Q4 2015. 8 funds tracked by Wall St. Rank hold MDVX as of Q3 2017.

  • UBS Group reported no remaining Medovex Corp. Common Stock position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 6,823 Medovex Corp. Common Stock shares in Q3 2017, an estimated $6K.
  • UBS Group first reported a position in Medovex Corp. Common Stock in Q1 2015 and held it in 9 quarters.
  • UBS Group's Medovex Corp. Common Stock position peaked at $51K in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.